We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
(+157%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
58.75%
Top 10 Holdings %
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$895K |
| 2 |
Photronics
PLAB
|
+$774K |
| 3 |
Edwards Lifesciences
EW
|
+$755K |
| 4 |
Maximus
MMS
|
+$754K |
| 5 |
Tetra Tech
TTEK
|
+$745K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$197K |
| 2 |
CoStar Group
CSGP
|
+$197K |
| 3 |
Vista Energy
VIST
|
+$197K |
| 4 |
SKX
Skechers
SKX
|
+$196K |
| 5 |
Alerus Financial
ALRS
|
+$195K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.59% |
| 3 | Industrials | 17.43% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Financials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
W&T Offshore
WTI
$545M
| $111K | 0.06% |
+51,626
| New | +$115K |
|
552
Amneal Pharmaceuticals
AMRX
$5.72B
| $106K | 0.06% |
+12,725
| New | +$99.5K |
|
553
NatWest
NWG
$71.5B
| $104K | 0.06% |
+11,124
| New | +$99K |
|
554
TScan Therapeutics
TCRX
$51.9M
| $103K | 0.06% |
+20,620
| New | +$124K |
|
555
RLJ Lodging Trust
RLJ
$1.87B
| $101K | 0.06% |
+11,035
| New | +$103K |
|
556
iQIYI
IQ
$1.18B
| $98.9K | 0.06% |
+34,564
| New | +$100K |
|
557
Xeris Biopharma Holdings
XERS
$1.44B
| $98.7K | 0.06% |
+34,633
| New | +$88.9K |
|
558
Kearny Financial
KRNY
$592M
| $96.7K | 0.06% |
+14,080
| New | +$92.9K |
|
559
MacroGenics
MGNX
$235M
| $92.7K | 0.05% |
+28,173
| New | +$110K |
|
560
Pulmonx
LUNG
$49.4M
| $92.4K | 0.05% |
+11,149
| New | +$80.7K |
|
561
JetBlue
JBLU
$1.96B
| $91.1K | 0.05% |
+13,885
| New | +$78.2K |
|
562
The Honest Company
HNST
$417M
| $90.3K | 0.05% |
+25,298
| New | +$94.8K |
|
563
Holley
HLLY
$314M
| $89.3K | 0.05% |
+30,262
| New | +$101K |
|
564
Gray Television
GTN
$407M
| $88.7K | 0.05% |
+16,542
| New | +$85.2K |
|
565
Custom Truck One Source
CTOS
$2.47B
| $87.1K | 0.05% |
+25,244
| New | +$106K |
|
|
DCH
566
Dauch Corp
DCH
$1.3B
| $81.8K | 0.05% |
13,241
+8,654
| +189% | +$56.4K |
|
567
BARK
BARK
$74.8M
| $78.8K | 0.04% |
+2,417
| New | +$78.6K |
|
568
Array Technologies
ARRY
$818M
| $73.4K | 0.04% |
+11,128
| New | +$91.5K |
|
|
NNDM
569
Nano Dimension
NNDM
$309M
| $71.6K | 0.04% |
+29,210
| New | +$65.8K |
|
570
The RealReal
REAL
$1.34B
| $71.4K | 0.04% |
22,737
+21,878
| +2,547% | +$65.8K |
|
571
Sight Sciences
SGHT
$267M
| $70.9K | 0.04% |
11,256
+6,053
| +116% | +$40.7K |
|
|
DENN
572
DELISTED
Denny's
DENN
| $69.6K | 0.04% |
+10,798
| New | +$70.6K |
|
|
SHCO
573
DELISTED
Soho House & Co
SHCO
| $69.3K | 0.04% |
+13,593
| New | +$74.5K |
|
574
Ironwood Pharmaceuticals
IRWD
$611M
| $68.7K | 0.04% |
+16,665
| New | +$89.6K |
|
575
Ocugen
OCGN
$410M
| $64.7K | 0.04% |
+65,174
| New | +$89.5K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q3 2024 Portfolio in Review
As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.
- EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
- EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
- EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
- EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
- EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
- EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
- EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.
Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.